CARBOPLATIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carboplatin, and when can generic versions of Carboplatin launch?
Carboplatin is a drug marketed by Cipla Ltd, Fresenius Kabi Usa, Hikma, Hospira, Natco Pharma Usa, Pliva, Sandoz, Watson Labs Teva, Accord Hlthcare, Actavis Totowa, Epic Pharma Llc, Eugia Pharma, Gland Pharma Ltd, Meitheal, Mylan Institutional, Mylan Labs Ltd, Novast Labs, Pharmachemie Bv, Pliva Lachema, Sun Pharm, Teva Parenteral, Teva Pharms Usa, and Teyro Labs. and is included in thirty-three NDAs.
The generic ingredient in CARBOPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the carboplatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carboplatin
A generic version of CARBOPLATIN was approved as carboplatin by HOSPIRA on October 14th, 2004.
Summary for CARBOPLATIN
US Patents: | 0 |
Applicants: | 23 |
NDAs: | 33 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Clinical Trials: | 2,930 |
Patent Applications: | 161 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CARBOPLATIN |
DailyMed Link: | CARBOPLATIN at DailyMed |
Recent Clinical Trials for CARBOPLATIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
CarThera | Phase 3 |
Aston Sci. Inc. | Phase 2 |
The First Affiliated Hospital of Zhengzhou University | Phase 2 |
Pharmacology for CARBOPLATIN
Drug Class | Platinum-based Drug |
Medical Subject Heading (MeSH) Categories for CARBOPLATIN
Anatomical Therapeutic Chemical (ATC) Classes for CARBOPLATIN
US Patents and Regulatory Information for CARBOPLATIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 091063-001 | Nov 9, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077139-002 | Sep 21, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eugia Pharma | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 205487-004 | Aug 3, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Actavis Totowa | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 078732-003 | Feb 6, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |